{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:46:12Z","timestamp":1781081172223,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","sempedneurjnl.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.spen.2016.06.004","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T17:10:56Z","timestamp":1465319456000},"page":"158-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Amenable Treatable Severe Pediatric Epilepsies"],"prefix":"10.1016","volume":"23","author":[{"given":"Phillip L.","family":"Pearl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.spen.2016.06.004_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1542\/peds.13.2.140","article-title":"Pyridoxine dependency: Report of a case of intractable convulsions in an infant controlled by pyridoxine","volume":"13","author":"Hunt","year":"1954","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.spen.2016.06.004_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm1366","article-title":"Mutations in antiquitin in individuals with pyridoxine-dependent seizures","volume":"12","author":"Mills","year":"2006","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.spen.2016.06.004_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00431-008-0823-x","article-title":"Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: Review of 63 North American cases submitted to a patient registry","volume":"168","author":"Basura","year":"2009","journal-title":"Eur J Pediatr"},{"issue":"5","key":"10.1016\/j.spen.2016.06.004_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.21568","article-title":"Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy","volume":"65","author":"Gallagher","year":"2009","journal-title":"Ann Neurol"},{"issue":"Pt 7","key":"10.1016\/j.spen.2016.06.004_bib5","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/brain\/awq143","article-title":"Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)","volume":"133","author":"Mills","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.spen.2016.06.004_bib6","first-page":"S73","article-title":"Vitamin B6 dependent seizures","volume":"36","author":"Plecko","year":"2009","journal-title":"Can J Neurol Sci"},{"issue":"7","key":"10.1016\/j.spen.2016.06.004_bib7","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1111\/j.1469-8749.2010.03660.x","article-title":"Seizures and paroxysmal events: Symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency","volume":"52","author":"Schmitt","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2016.06.004_bib8","series-title":"GeneReviews. [[Internet] Copyright 1993-2015]","article-title":"Pyridoxine-dependent epilepsy","author":"Gospe","year":"2014"},{"issue":"1-2","key":"10.1016\/j.spen.2016.06.004_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymgme.2011.05.014","article-title":"Pyridoxine dependent epilepsy and antiquitin deficiency: Clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up","volume":"104","author":"Stockler","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"6","key":"10.1016\/j.spen.2016.06.004_bib10","doi-asserted-by":"crossref","first-page":"e1716","DOI":"10.1542\/peds.2012-1094","article-title":"Pyridoxine-dependent epilepsy with elevated urinary alpha-amino adipic semialdehyde in molybdenum cofactor deficiency","volume":"130","author":"Struys","year":"2012","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.spen.2016.06.004_bib11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1212\/WNL.0000000000001883","article-title":"Intragenic deletions of ALDH7A1 in pyridoxine-dependent epilepsy caused by Alu-Alu recombination","volume":"85","author":"Mefford","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2016.06.004_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/8904_2014_296","article-title":"Lysine-restricted diet as adjunct therapy for pyridoxine-dependent epilepsy: The PDE Consortium Consensus Recommendations","volume":"15","author":"van Karnebeek","year":"2014","journal-title":"JIMD Rep."},{"issue":"1\u20132","key":"10.1016\/j.spen.2016.06.004_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymgme.2015.05.011","article-title":"Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: Neurodevelopmental outcome","volume":"116","author":"Coughlin","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2016.06.004_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/8904_2015_460","article-title":"Seizures due to a KCNQ2 mutation: Treatment with vitamin B","author":"Reid","year":"2015","journal-title":"JIMD Rep"},{"issue":"2\u20133","key":"10.1016\/j.spen.2016.06.004_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10545-005-0243-2","article-title":"B6-responsive disorders: A model of vitamin dependency","volume":"29","author":"Clayton","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.spen.2016.06.004_bib16","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1007\/s10545-009-9012-y","article-title":"Perinatal hypophosphatasia presenting as neonatal epileptic encephalopathy with abnormal neurotransmitter metabolism secondary to reduced co-factor pyridoxal-5\u2032-phosphate availability","volume":"33","author":"Balasubramaniam","year":"2010","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.spen.2016.06.004_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10545-008-9974-1","article-title":"Pyridoxal phosphate dependency: A newly recognized treatable catastrophic epileptic encephalopathy","volume":"30","author":"Pearl","year":"2007","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"10.1016\/j.spen.2016.06.004_bib18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1469-8749.2010.03705.x","article-title":"Recent insights into pre- and postnatal pyridoxal phosphate deficiency, a treatable metabolic encephalopathy","volume":"52","author":"Baxter","year":"2010","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"10.1016\/j.spen.2016.06.004_bib19","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/hmg\/ddi120","article-title":"Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5\u2032-phosphate oxidase","volume":"14","author":"Mills","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"16","key":"10.1016\/j.spen.2016.06.004_bib20","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/WNL.0000000000000344","article-title":"Pyridoxine responsiveness in novel mutations of the PNPO gene","volume":"82","author":"Plecko","year":"2014","journal-title":"Neurology"},{"issue":"Pt 5","key":"10.1016\/j.spen.2016.06.004_bib21","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/brain\/awu051","article-title":"Epilepsy due to PNPO mutations: Genotype, environment and treatment affect presentation and outcome","volume":"137","author":"Mills","year":"2014","journal-title":"Brain"},{"issue":"16","key":"10.1016\/j.spen.2016.06.004_bib22","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1212\/WNL.0000000000000351","article-title":"Pyridoxine or pyridoxal-5\u2032-phosphate for neonatal epilepsy: The distinction just got murkier","volume":"82","author":"Pearl","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2016.06.004_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/8904_2015_413","article-title":"Normal cerebrospinal fluid pyridoxal 5\u2032-phosphate level in a PNPO-deficient patient with neonatal-onset epileptic encephalopathy","volume":"22","author":"Levtova","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.spen.2016.06.004_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/8904_2014_338","article-title":"Cirrhosis associated with pyridoxal 5\u2032-phosphate treatment of pyridoxamine 5\u2032-phosphate oxidase deficiency","volume":"17","author":"Sudarsanam","year":"2014","journal-title":"JIMD Rep"},{"issue":"5","key":"10.1016\/j.spen.2016.06.004_bib25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/dmcn.12346","article-title":"Typical and atypical phenotypes of PNPO deficiency with elevated CSF and plasma pyridoxamine on treatment","volume":"56","author":"Ware","year":"2014","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"10.1016\/j.spen.2016.06.004_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/GIM.0b013e3181e4cc0f","article-title":"Working Group of the American College of Medical Genetics Laboratory Quality Assurance C. Technical standards and guidelines for the diagnosis of biotinidase deficiency","volume":"12","author":"Cowan","year":"2010","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.spen.2016.06.004_bib27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1586\/17446651.3.6.715","article-title":"Biotin and biotinidase deficiency","volume":"3","author":"Zempleni","year":"2008","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.spen.2016.06.004_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2010.01.003","article-title":"Clinical issues and frequent questions about biotinidase deficiency","volume":"100","author":"Wolf","year":"2010","journal-title":"Mol Genet Metab"},{"issue":"7","key":"10.1016\/j.spen.2016.06.004_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(14)70110-3","article-title":"Occasional seizures, epilepsy, and inborn errors of metabolism","volume":"13","author":"Dulac","year":"2014","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.spen.2016.06.004_bib30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s00247-008-0904-z","article-title":"Biotinidase deficiency: A reversible metabolic encephalopathy. Neuroimaging and MR spectroscopic findings in a series of four patients","volume":"38","author":"Desai","year":"2008","journal-title":"Pediatr Radiol"},{"issue":"7","key":"10.1016\/j.spen.2016.06.004_bib31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.braindev.2009.02.008","article-title":"The expanding phenotype of GLUT1-deficiency syndrome","volume":"31","author":"Brockmann","year":"2009","journal-title":"Brain Dev"},{"issue":"10","key":"10.1016\/j.spen.2016.06.004_bib32","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJM199109053251006","article-title":"Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay","volume":"325","author":"De Vivo","year":"1991","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.spen.2016.06.004_bib33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ana.22088","article-title":"Glut1 deficiency: Inheritance pattern determined by haploinsufficiency","volume":"68","author":"Rotstein","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2016.06.004_bib34","series-title":"[[Internet] Copyright 1993-2015] GeneReviews","article-title":"Glucose transporter type 1 deficiency syndrome","author":"Wang","year":"2015"},{"key":"10.1016\/j.spen.2016.06.004_bib35","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3897","article-title":"Inherited disorders of folate and cobalamin transport and metabolism","author":"Rosenblatt","year":"2000"},{"issue":"6","key":"10.1016\/j.spen.2016.06.004_bib36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ana.410130624","article-title":"Folate metabolism disorder in Kearns-Sayre syndrome","volume":"13","author":"Dougados","year":"1983","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.spen.2016.06.004_bib37","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ana.20746","article-title":"Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion","volume":"59","author":"Pineda","year":"2006","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.spen.2016.06.004_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymgme.2009.08.005","article-title":"Cerebral folate deficiency and CNS inflammatory markers in Alpers disease","volume":"99","author":"Hasselmann","year":"2010","journal-title":"Mol Genet Metab"},{"issue":"6","key":"10.1016\/j.spen.2016.06.004_bib39","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1212\/01.WNL.0000154641.08211.B7","article-title":"Cerebral folate deficiency with developmental delay, autism, and response to folinic acid","volume":"64","author":"Moretti","year":"2005","journal-title":"Neurology"},{"issue":"Pt 7","key":"10.1016\/j.spen.2016.06.004_bib40","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/brain\/121.7.1267","article-title":"Biotin-responsive basal ganglia disease: A novel entity","volume":"121","author":"Ozand","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.spen.2016.06.004_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-8-83","article-title":"Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: A retrospective review of the clinical, radiological and molecular findings of 18 new cases","volume":"8","author":"Alfadhel","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2016.06.004_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1750-1172-9-92","article-title":"Thiamine transporter-2 deficiency: outcome and treatment monitoring","volume":"9","author":"Ortigoza-Escobar","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.spen.2016.06.004_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/431216","article-title":"Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3","volume":"77","author":"Zeng","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.spen.2016.06.004_bib44","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ymgme.2009.10.012","article-title":"L-serine synthesis in the central nervous system: A review on serine deficiency disorders","volume":"99","author":"Tabatabaie","year":"2010","journal-title":"Mol Genet Metab"},{"issue":"9452","key":"10.1016\/j.spen.2016.06.004_bib45","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(04)17596-X","article-title":"Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency","volume":"364","author":"de Koning","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.spen.2016.06.004_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-2000-12944","article-title":"Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency","volume":"31","author":"de Koning","year":"2000","journal-title":"Neuropediatrics"},{"issue":"5","key":"10.1016\/j.spen.2016.06.004_bib47","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/BF01799850","article-title":"Combined deficiency of xanthine oxidase and sulphite oxidase due to a deficiency of molybdenum cofactor","volume":"19","author":"Bonioli","year":"1996","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.spen.2016.06.004_bib48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF00735420","article-title":"The detection of molybdenum cofactor deficiency: Clinical symptomatology and urinary metabolite profile","volume":"17","author":"van Gennip","year":"1994","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.spen.2016.06.004_bib49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pediatrneurol.2011.06.006","article-title":"Clinical neuroimaging features and outcome in molybdenum cofactor deficiency","volume":"45","author":"Vijayakumar","year":"2011","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.spen.2016.06.004_bib50","doi-asserted-by":"crossref","first-page":"e1249","DOI":"10.1542\/peds.2009-2192","article-title":"Successful treatment of molybdenum cofactor deficiency type A with cPMP","volume":"125","author":"Veldman","year":"2010","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.spen.2016.06.004_bib51","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2001-12217","article-title":"Cobalamin (Cbl) C\/D deficiency: Clinical, neurophysiological and neuroradiologic findings in 14 cases","volume":"32","author":"Biancheri","year":"2001","journal-title":"Neuropediatrics."},{"issue":"1","key":"10.1016\/j.spen.2016.06.004_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajmg.c.20007","article-title":"Type I glutaric aciduria, part 1: Natural history of 77 patients","volume":"121C","author":"Strauss","year":"2003","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"3","key":"10.1016\/j.spen.2016.06.004_bib53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10545-011-9289-5","article-title":"Diagnosis and management of glutaric aciduria type I\u2014Revised recommendations","volume":"34","author":"Kolker","year":"2011","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.spen.2016.06.004_bib54","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1023\/B:BOLI.0000045771.66300.2a","article-title":"Neuroradiological findings in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency)","volume":"27","author":"Neumaier-Probst","year":"2004","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.spen.2016.06.004_bib55","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1399-0004.2010.01460.x","article-title":"Clinical features and X-inactivation in females heterozygous for creatine transporter defect","volume":"79","author":"van de Kamp","year":"2011","journal-title":"Clin Genet"},{"issue":"10","key":"10.1016\/j.spen.2016.06.004_bib56","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1651-2227.2008.00952.x","article-title":"Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes","volume":"97","author":"Summar","year":"2008","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.spen.2016.06.004_bib57","series-title":"GeneReviews","article-title":"Urea cycle disorders overview","author":"Ah Mew","year":"2014"},{"issue":"3","key":"10.1016\/j.spen.2016.06.004_bib58","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1176\/jnp.2008.20.3.369","article-title":"Valproate-induced hyperammonemic encephalopathy without cognitive sequelae: A case report in the psychiatric setting","volume":"20","author":"Dealberto","year":"2008","journal-title":"J Neuropsychiatry Clin Neurosc"},{"issue":"13","key":"10.1016\/j.spen.2016.06.004_bib59","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1212\/01.wnl.0000268488.51776.53","article-title":"A novel mutation causing DEND syndrome: A treatable channelopathy of pancreas and brain","volume":"69","author":"Shimomura","year":"2007","journal-title":"Neurology"},{"issue":"18","key":"10.1016\/j.spen.2016.06.004_bib60","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes","volume":"350","author":"Gloyn","year":"2004","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.spen.2016.06.004_bib61","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/hmg\/ddl101","article-title":"A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes","volume":"15","author":"Proks","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.spen.2016.06.004_bib62","doi-asserted-by":"crossref","first-page":"E880","DOI":"10.1152\/ajpendo.00348.2007","article-title":"The Walter B. Cannon Physiology in Perspective Lecture, 2007. ATP-sensitive K+ channels and disease: From molecule to malady","volume":"293","author":"Ashcroft","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.spen.2016.06.004_bib63","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.2337\/dc07-1196","article-title":"Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene: Improvement in glycemic control and neurological function","volume":"30","author":"Gurgel","year":"2007","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.spen.2016.06.004_bib64","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ncpneuro0640","article-title":"Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11","volume":"3","author":"Mlynarski","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"issue":"4","key":"10.1016\/j.spen.2016.06.004_bib65","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0889-8529(05)70097-9","article-title":"Hyperinsulinemic hypoglycemia of infancy. Recent insights into ATP-sensitive potassium channels, sulfonylurea receptors, molecular mechanisms, and treatment","volume":"28","author":"Sperling","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10.1016\/j.spen.2016.06.004_bib66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11154-010-9146-0","article-title":"The hyperinsulinism\/hyperammonemia syndrome","volume":"11","author":"Palladino","year":"2010","journal-title":"Rev Endocr Metab Disord"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1071909116300109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1071909116300109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T05:11:10Z","timestamp":1656652270000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909116300109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1071909116300109"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2016.06.004","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amenable Treatable Severe Pediatric Epilepsies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.spen.2016.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}